Premium Company

Neopharma, UAE’s premier pharmaceutical manufacturing company commenced operations in 2003 with the vision to locally manufacture world class pharmaceuticals at affordable prices. From a single manufacturing unit, Neopharma today has become a global pharmaceutical company supported by 8 manufacturing facilities spread across 3 continents delivering branded and generic formulations, and active pharmaceutical ingredients (APIs). The product portfolio covers 100 high-quality molecules in 9 therapy areas including anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental and nutritionals. Driven by innovation, Neopharma lays strong emphasis on research, especially towards development of processes and products that are patent non-infringing. Neopharma currently caters to over 50 international markets including Middle East, Africa, CIS, USA and South East Asia. 

For further information, please visit

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Contact information




View All Contact Info